Volume 14, Issue 4 (2-2001)                   Med J Islam Repub Iran 2001 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
ZAMANI A, SHAJARI H, SEDIGHY I. STUDY ON THE EF FICACY OF RECOMBINANT HEPATITIS B VACCINE IN IRANIAN INFANTS. Med J Islam Repub Iran 2001; 14 (4) :347-349
URL: http://mjiri.iums.ac.ir/article-1-835-en.html
STUDY ON THE EF FICACY OF RECOMBINANT HEPATITIS B VACCINE IN IRANIAN INFANTS
A ZAMANI , H SHAJARI , I SEDIGHY
From the Departments of Pediatrics School of Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.
Abstract:   (4207 Views)
In order to determine the efficacy of recombinant hepatitis B vaccine in Iranian infants, we analyzed the efficacy of a recombinant hepatitis B vaccine in 115 infants aged 12-24 months born to HBsAg negative mothers who received three doses of HBV Antibody to hepatitis B surface antigen (anti-HBs) was checked after the third dose of the vaccine, 94.8% of the infants had developed protective antibody levels. The vaccine was well-tolerated and no serious adverse effects were reported. This study is in agreement with a WHO report which recommends that the easiest and most cost-effective strategy for the control and eventual eradication of HBV would be to immunize all newborns with hepatitis B vaccine only [World Health Organization report, 1984].
Keywords: hepatitis B vaccine, infant, efficacy, immunization.
Full-Text [PDF 425 kb]   (2206 Downloads)    
Type of Study: Original Research | Subject: Pediatric
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.